Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Ligand Pharmaceuticals (LGND) over the last 12 years, with Dec 2024 value amounting to $8.1 million.

  • Ligand Pharmaceuticals' Interest & Investment Income rose 187.60% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year increase of 17.65%. This contributed to the annual value of $8.1 million for FY2024, which is 4.46% up from last year.
  • According to the latest figures from FY2024, Ligand Pharmaceuticals' Interest & Investment Income is $8.1 million, which was up 4.46% from $7.7 million recorded in FY2023.
  • In the past 5 years, Ligand Pharmaceuticals' Interest & Investment Income ranged from a high of $8.1 million in FY2020 and a low of $886,000 during FY2021.
  • Its 3-year average for Interest & Investment Income is $5.9 million, with a median of $7.7 million in 2023.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first slumped by 89.03% in 2021, then spiked by 276.88% in 2023.
  • Yearly analysis of 5 years shows Ligand Pharmaceuticals' Interest & Investment Income stood at $8.1 million in 2020, then tumbled by 89.03% to $886,000 in 2021, then surged by 130.93% to $2.0 million in 2022, then skyrocketed by 276.88% to $7.7 million in 2023, then climbed by 4.46% to $8.1 million in 2024.